Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications

Abstract Background DNA hypermethylation at promoter CpG islands (CGIs) is a hallmark of cancers and could lead to dysregulation of gene expression in the development of cancers, however, its dynamics and regulatory mechanisms remain elusive. Bivalent genes, that direct development and differentiati...

Full description

Bibliographic Details
Main Authors: Yang Lu, Qiang Cao, Yue Yu, Yazhou Sun, Xuan Jiang, Xin Li
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12864-023-09341-1
_version_ 1797832236328812544
author Yang Lu
Qiang Cao
Yue Yu
Yazhou Sun
Xuan Jiang
Xin Li
author_facet Yang Lu
Qiang Cao
Yue Yu
Yazhou Sun
Xuan Jiang
Xin Li
author_sort Yang Lu
collection DOAJ
description Abstract Background DNA hypermethylation at promoter CpG islands (CGIs) is a hallmark of cancers and could lead to dysregulation of gene expression in the development of cancers, however, its dynamics and regulatory mechanisms remain elusive. Bivalent genes, that direct development and differentiation of stem cells, are found to be frequent targets of hypermethylation in cancers. Results Here we performed comprehensive analysis across multiple cancer types and identified that the decrease in H3K4me1 levels coincides with DNA hypermethylation at the bivalent promoter CGIs during tumorigenesis. Removal of DNA hypermethylation leads to increment of H3K4me1 at promoter CGIs with preference for bivalent genes. Nevertheless, the alteration of H3K4me1 by overexpressing or knockout LSD1, the demethylase of H3K4, doesn’t change the level or pattern of DNA methylation. Moreover, LSD1 was found to regulate the expression of a bivalent gene OVOL2 to promote tumorigenesis. Knockdown of OVOL2 in LSD1 knockout HCT116 cells restored the cancer cell phenotype. Conclusion In summary, our work identified a universal indicator that can pre-mark DNA hypermethylation in cancer cells, and dissected the interplay between H3K4me1 and DNA hypermethylation in detail. Current study also reveals a novel mechanism underlying the oncogenic role of LSD1, providing clues for cancer therapies.
first_indexed 2024-04-09T14:04:35Z
format Article
id doaj.art-947060ed4e7c4b5db9756d7d7d10fdf4
institution Directory Open Access Journal
issn 1471-2164
language English
last_indexed 2024-04-09T14:04:35Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Genomics
spelling doaj.art-947060ed4e7c4b5db9756d7d7d10fdf42023-05-07T11:06:26ZengBMCBMC Genomics1471-21642023-05-0124111910.1186/s12864-023-09341-1Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modificationsYang Lu0Qiang Cao1Yue Yu2Yazhou Sun3Xuan Jiang4Xin Li5School of Medicine, Shenzhen Campus of Sun Yat-Sen UniversitySchool of Medicine, Shenzhen Campus of Sun Yat-Sen UniversitySchool of Medicine, Shenzhen Campus of Sun Yat-Sen UniversityThe Seventh Affiliated Hospital of Sun Yat-Sen UniversitySchool of Medicine, Shenzhen Campus of Sun Yat-Sen UniversitySchool of Medicine, Shenzhen Campus of Sun Yat-Sen UniversityAbstract Background DNA hypermethylation at promoter CpG islands (CGIs) is a hallmark of cancers and could lead to dysregulation of gene expression in the development of cancers, however, its dynamics and regulatory mechanisms remain elusive. Bivalent genes, that direct development and differentiation of stem cells, are found to be frequent targets of hypermethylation in cancers. Results Here we performed comprehensive analysis across multiple cancer types and identified that the decrease in H3K4me1 levels coincides with DNA hypermethylation at the bivalent promoter CGIs during tumorigenesis. Removal of DNA hypermethylation leads to increment of H3K4me1 at promoter CGIs with preference for bivalent genes. Nevertheless, the alteration of H3K4me1 by overexpressing or knockout LSD1, the demethylase of H3K4, doesn’t change the level or pattern of DNA methylation. Moreover, LSD1 was found to regulate the expression of a bivalent gene OVOL2 to promote tumorigenesis. Knockdown of OVOL2 in LSD1 knockout HCT116 cells restored the cancer cell phenotype. Conclusion In summary, our work identified a universal indicator that can pre-mark DNA hypermethylation in cancer cells, and dissected the interplay between H3K4me1 and DNA hypermethylation in detail. Current study also reveals a novel mechanism underlying the oncogenic role of LSD1, providing clues for cancer therapies.https://doi.org/10.1186/s12864-023-09341-1CancerPromoter CGIsDNA methylationH3K4me1LSD1Bivalent promoters
spellingShingle Yang Lu
Qiang Cao
Yue Yu
Yazhou Sun
Xuan Jiang
Xin Li
Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
BMC Genomics
Cancer
Promoter CGIs
DNA methylation
H3K4me1
LSD1
Bivalent promoters
title Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
title_full Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
title_fullStr Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
title_full_unstemmed Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
title_short Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
title_sort pan cancer analysis revealed h3k4me1 at bivalent promoters premarks dna hypermethylation during tumor development and identified the regulatory role of dna methylation in relation to histone modifications
topic Cancer
Promoter CGIs
DNA methylation
H3K4me1
LSD1
Bivalent promoters
url https://doi.org/10.1186/s12864-023-09341-1
work_keys_str_mv AT yanglu pancanceranalysisrevealedh3k4me1atbivalentpromoterspremarksdnahypermethylationduringtumordevelopmentandidentifiedtheregulatoryroleofdnamethylationinrelationtohistonemodifications
AT qiangcao pancanceranalysisrevealedh3k4me1atbivalentpromoterspremarksdnahypermethylationduringtumordevelopmentandidentifiedtheregulatoryroleofdnamethylationinrelationtohistonemodifications
AT yueyu pancanceranalysisrevealedh3k4me1atbivalentpromoterspremarksdnahypermethylationduringtumordevelopmentandidentifiedtheregulatoryroleofdnamethylationinrelationtohistonemodifications
AT yazhousun pancanceranalysisrevealedh3k4me1atbivalentpromoterspremarksdnahypermethylationduringtumordevelopmentandidentifiedtheregulatoryroleofdnamethylationinrelationtohistonemodifications
AT xuanjiang pancanceranalysisrevealedh3k4me1atbivalentpromoterspremarksdnahypermethylationduringtumordevelopmentandidentifiedtheregulatoryroleofdnamethylationinrelationtohistonemodifications
AT xinli pancanceranalysisrevealedh3k4me1atbivalentpromoterspremarksdnahypermethylationduringtumordevelopmentandidentifiedtheregulatoryroleofdnamethylationinrelationtohistonemodifications